Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system (Q84582933)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2013

Language	Label	Description	Also known as
English	Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system	scientific article published on 01 January 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Yi-Hsiang Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Chia-Yang Hsu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yun-Hsuan Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Cheng-Yuan Hsia

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Han-Chieh Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Rheun-Chuan Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yi-You Chiou

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Fa-Yauh Lee

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Teh-Ia Huo

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

1 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

57

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

112-119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating kidney function in adults using formulae.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of goodness-of-fit tests for the logistic regression model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical biostatistics. XVI. The process of prognostic stratification. 2.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Third-line or fourth-line chemotherapy in non-small-cell lung cancer patients with relatively good performance status

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence-based incorporation of serum sodium concentration into MELD

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Major adverse events, pretransplant assessment and outcome prediction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Model to estimate survival in ambulatory patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25950

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.25950

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22806819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84582933&oldid=1671790863"